Загрузка...
Detection of Alzheimer’s Disease Pathology in patients using biochemical biomarkers: prospects and challenges for use in clinical practice.
BACKGROUND: Amyloid-β1-42 peptide was identified 34 years ago in amyloid plaques obtained from Alzheimer’s disease (AD) and Down’s Syndrome patients’ autopsied brain tissue. This led to development of immunoassay methods for measuring this marker of amyloid plaque burden in cerebrospinal fluid (CSF)...
Сохранить в:
| Опубликовано в: : | J Appl Lab Med |
|---|---|
| Главные авторы: | , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2020
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7246169/ https://ncbi.nlm.nih.gov/pubmed/31848218 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1373/jalm.2019.029587 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|